Point-of-Care Compatibility of Ultra-Sensitive Detection Techniques for the Cardiac Biomarker Troponin I—Challenges and Potential Value
<div><p>Cardiac biomarkers are frequently measured to provide guidance on the well-being of a patient in relation to cardiac health with many assays having been developed and widely utilised in clinical assessment. Effectively treating and managing cardiovascular disease (CVD) relies on...
Saved in:
| Main Author: | Brian Regan (18418860) (author) |
|---|---|
| Other Authors: | Richard O’Kennedy (713891) (author), David Collins (2195629) (author) |
| Published: |
2018
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Molecularly Imprinted Polymers for Point-of-Care Testing for Cardiovascular Disease
by: Brian Regan (18418860)
Published: (2019) -
Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I
by: Radha, Remya
Published: (2021) -
Fluorescent Immunoassays for Detection and Quantification of Cardiac Troponin I: A Short Review
by: Radha, Remya
Published: (2021) -
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
by: Akl C. Fahed (11514346)
Published: (2020) -
Can absence of cardiac activity on point-of-care echocardiography predict death in out-of-hospital cardiac arrest? A systematic review and meta-analysis
by: Omar Albaroudi (16122240)
Published: (2024)